Chemistry: analytical and immunological testing – Hemoglobin – myoglobin – or occult blood
Reexamination Certificate
2007-05-29
2007-05-29
Wallenhorst, Maureen M. (Department: 1743)
Chemistry: analytical and immunological testing
Hemoglobin, myoglobin, or occult blood
C436S063000, C436S164000, C436S172000, C422S082050, C422S082080
Reexamination Certificate
active
10673538
ABSTRACT:
Methods and kits useful in the detection of occult blood in biological samples and specimens, for example to screen for colorectal cancer or detect blood in samples ex vivo, e.g., at a crime scene. Also provided are methods useful in diagnosing whether a subject is predisposed to, or suffers from, an occult-blood related disorder; and methods for direct micro-mapping of the distribution of occluded vessels associated with cerebral vascular injury.
REFERENCES:
patent: 4378971 (1983-04-01), Schwartz
patent: 5563071 (1996-10-01), Augurt
patent: 5665308 (1997-09-01), Watanabe
patent: 5702913 (1997-12-01), Guadagno
patent: 5840584 (1998-11-01), Waldenburg
patent: 5922544 (1999-07-01), Miyai et al.
patent: 5929031 (1999-07-01), Kerwin et al.
patent: 6207113 (2001-03-01), Kagaya
patent: 2004/0171016 (2004-09-01), Tomita et al.
Liu et al. Journal of Cerebral Blood Flow & Metabolism, vol. 22(10), Oct. 2002, pp. 1222-1230.
Ahlquist et al. “Accuracy of fecal occult blood screening for colorectal neoplasia. A prospective study using Hemoccult and HemoQuant tests”JAMA1993;269(10):1262-67.
Ahlquist, “Approach to the patient with occult gastrointestinal bleeding:” In: Yamada ed.Textbook of gastroenterology, 2(1) Philadelphia J.B. Lippincott, 1995;699-717.
Ahlquist et al. “Patterns of occult bleeding in asymptomatic colorectal cancer.”Cancer1989;63:1826-30.
Allison et al. “A comparison of fecal occult-blood tests for colorectal-cancer screening.”N Engl J Med1996;334(3):155-9.
Ames et al. “Cerebral ischemia. II. The no-reflow phenomenon”Am J Pathol1968:52:437-53.
Bederson et al. “Evaluation of 2, 3, 5-Triphenyltetrazolium Chloride as a Stain for Detection and Quantification of Experimental Cerebral Infraction in Rats” Stroke 1986;17(6):1304-8.
Byers et al., American Cancer Society guidelines for screening and surveillance for early detection of colorectal polyps and cancer. Update 1997.CA Cancer J Clin1997;47(3):154-60.
Clancy et al. “Reduction of background autofluorescence in brain sections following immersion in sodium borohydride.”J Neurosci Methods1998;83:97-102.
Czurkó et al. “‘Collapsed’ (argyophilic, dark) neurons in rat model of transient focal cerebral ischemia”Neurosci Ltt.1993:162:71-4.
Eisner et al. “Diagnostic yield of a positive fecal occult blood test found on digital rectal examination. Does the finger count?”Arch Intern Med1991;151:2180-4.
Ferrucci, Joseph T., “Colonoscopy and barium enema: radiologist's response.”Gastroenterology1997;112(1):294-7.
Fleisher et al. “Accuracy of fecal occult blood test interpretation.”Ann Intern Med1991;114(10):875-6.
Gouterman, Martin, “Optical Spectra and Electronic Structure of Porphyrins and Related Rings,”The Porphyrins, vol. III , New York:Academic Press 1978; title page, pp. 1-165.
“Hemoccult fecal blood test” datasheet [online]. Beckman Coulter, Inc. Fullerton, CA, [retrieved on Sep. 22, 2005]. Retrieved from the Internet:<URL: www.beckman.com/products/RapidTestKits/hemoccult.asp>; 3 pgs.
Hermann et al. “Relationship between metabolic dysfunctions, gene responses and delayed cell death after mild focal cerebral ischemia in mice,”Neuroscience2001;104/(4);947-955.
Kalimo et al. “Structural aspects of ischemic brain damage” Acta Neurochir Suppl (Wien) 1986:36,129-32.
Lang et al. “Fecal occult blood screening for colorectal cancer. Is mortality reduced by chance selection for screening colonoscopy?”JAMA1994;271(13):1011-3.
Lide, ed.,CRC Handbook of Chemistry and Physics, Boca Raton, Florida 1999; cover page, title page and table of contents, 8-21-8-31.
Liu et al. “Visualization of the early “no-reflow phenomenon” in rats subjected to focal cerebral ischemia and reperfusion”Society for Neuroscience Abstracts2001;27(1):1157. Abstract Only.
Longa et al. “Reversible Middle Cerebral Artery Occlusion Without Craniectomy in Rats” Stroke 1989;20(1):84-91.
Mandel et al. “Colorectal Cancer Mortality: Effectiveness of Biennial Screening for Fecal Occult Blood”J of the National Cancer Institute1999;91(5):434-7.
Mandel et al. “Reducing mortality from colorectal cancer by screening for fecal occult blood”N Engl J Med1993;328(19):1365-71.
Onizuka et al. “Early cytopathic features in rat ischemia model and reconstruction by neural graft.”Exp Neurol1996;137(2), 324-32.
“Package Insert EZ Detect Product”datasheet [online]. Test Medical Symptoms @ Home, Inc., Maria Stein, OH [retrieved on Sep. 22, 2005]. Retrieved from the Internet:<URL: www.testsymptomsathome.com/BII01—package—insert.asp>; 7 pgs.
Petito et al. “DNA fragmentation follows delayed neuronal death in CA1 neurons exposed to transient global ischemia in the rat.”J Cereb Blood Flow Metab1997;17(9):967-976.
Radovsky et al. “Ischemic neurons in rat brains after 6, 8, or 10 minutes of transient hypoxic ischemia.”Toxicol Pathol1997;25(5):500-5.
Rex et al. “Relative sensitivity of colonoscopy and barium enema for detection of colorectal cancer in clinical practice.”Gastroenterology1997;112(1):17-23.
Rockey et al. “Relative frequency of upper gastrointestinal and colonic lesions in patients with positive fecal occult-blood tests.”N Engl J Med1998;339(3):153-9.
Rockey et al. “Detection of Upper Gastrointestinal Blood with Fecal Occult Blood Tests”Am. J. Gastroenterol1999;94(2):344-50.
Schwartz et al. “The “HemoQuant” test: a specific and quantitative determination of heme (hemoglobin) in feces and other materials.”Clin Chem1983;29(12):2061-7.
Stroehlein et al., “Hemoccult detection of fecal occult blood quantitated by radioassay.”Am J Dig Dis1976;21:841-44.
Tanaka et al. “Induction of glyceraldehyde-3-phosphate dehyrogenase (GAPDH) expression in rat brain after focal ischemia/reperfusion”Journal of Cerebral Blood Flow and Metabolism2002;22(3):280-8.
United States Preventive Services Task Force. Guide to Clinical Preventive Services, 2nded, Williams & Wilkins, Baltimore 1996. Title Page and Table of Contents.
University of Alberta Laboratory Chemical Safety Manual. Feb. 2003. Cover Page, Table of Contents, pp. 47-48.
Waye, Jerome T., “What is a gold standard for colon polyps?”Gatroenterology1997;112:292-4.
Winawer et al. “Prevention of colorectal cancer: Guidelines based on new data.” Bull World Health Organ 1995; 73(1):7-10.
Liu Ke J.
Liu Shimin
Mueting, Raasch and Gebhardt, P.A.
Science & Technology Corporation @ UNM
Wallenhorst Maureen M.
LandOfFree
Methods and kits for the detection of erythrocytes does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods and kits for the detection of erythrocytes, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods and kits for the detection of erythrocytes will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3803568